Bonomini A, Mercorelli B, Loregian A
Cell Mol Life Sci. 2025; 82(1):75.
PMID: 39945883
PMC: 11825441.
DOI: 10.1007/s00018-025-05611-1.
Rosero C, Gravenstein S, Saade E
Drugs Aging. 2025; 42(1):39-55.
PMID: 39775605
DOI: 10.1007/s40266-024-01169-y.
Sato M
Fukushima J Med Sci. 2024; 71(1):1-12.
PMID: 39694499
PMC: 11799661.
DOI: 10.5387/fms.24-00029.
Takashita E, Shimizu K, Usuku S, Senda R, Okubo I, Morita H
Euro Surveill. 2024; 29(50).
PMID: 39668762
PMC: 11650510.
DOI: 10.2807/1560-7917.ES.2024.29.50.2400786.
Gao R, Pascua P, Chesnokov A, Nguyen H, Uyeki T, Mishin V
Emerg Infect Dis. 2024; 30(11):2303-2312.
PMID: 39378870
PMC: 11521183.
DOI: 10.3201/eid3011.240892.
Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy.
Batool S, Chokkakula S, Song M
Microorganisms. 2023; 11(1).
PMID: 36677475
PMC: 9865513.
DOI: 10.3390/microorganisms11010183.
The arrival of highly pathogenic avian influenza viruses H5N8 in Iran through two windows, 2016.
Motahhar M, Keyvanfar H, Shoushtari A, Fallah Mehrabadi M, Nikbakht Brujeni G
Virus Genes. 2022; 58(6):527-539.
PMID: 36098944
DOI: 10.1007/s11262-022-01930-8.
Population analysis of oseltamivir-resistant variants for the rapid prediction of drug susceptibility by real-time reverse transcription polymerase chain reaction.
Sato M, Hashimoto K, Hosoya M
Fukushima J Med Sci. 2022; 68(3):153-159.
PMID: 36047170
PMC: 9840889.
DOI: 10.5387/fms.2022-15.
Oseltamivir Treatment for Influenza During the Flu Season of 2018-2019: A Longitudinal Study.
Li X, Chen J, Wang W, Lin F, Li L, Liang J
Front Microbiol. 2022; 13:865001.
PMID: 35620096
PMC: 9127596.
DOI: 10.3389/fmicb.2022.865001.
Preclinical and clinical developments for combination treatment of influenza.
Koszalka P, Subbarao K, Baz M
PLoS Pathog. 2022; 18(5):e1010481.
PMID: 35551301
PMC: 9098076.
DOI: 10.1371/journal.ppat.1010481.
Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020.
Mohan T, Nguyen H, Kniss K, Mishin V, Merced-Morales A, Laplante J
Emerg Infect Dis. 2021; 27(7):1953-1957.
PMID: 34152954
PMC: 8237887.
DOI: 10.3201/eid2707.204593.
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
Lee L, Zhou J, Koszalka P, Frise R, Farrukee R, Baba K
PLoS Pathog. 2021; 17(5):e1009527.
PMID: 33956888
PMC: 8130947.
DOI: 10.1371/journal.ppat.1009527.
Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil.
Hashimoto T, Baba K, Inoue K, Okane M, Hata S, Shishido T
Influenza Other Respir Viruses. 2020; 15(3):389-395.
PMID: 33099886
PMC: 8051730.
DOI: 10.1111/irv.12821.
Semisynthetic Cardenolides Acting as Antiviral Inhibitors of Influenza A Virus Replication by Preventing Polymerase Complex Formation.
Boff L, Schreiber A, da Rocha Matos A, Del Sarto J, Brunotte L, Munkert J
Molecules. 2020; 25(20).
PMID: 33096707
PMC: 7587960.
DOI: 10.3390/molecules25204853.
Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity.
Vidana B, Martinez-Orellana P, Martorell J, Baratelli M, Martinez J, Migura-Garcia L
Viruses. 2020; 12(8).
PMID: 32721992
PMC: 7472233.
DOI: 10.3390/v12080794.
Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
Mawatari M, Saito R, Hibino A, Kondo H, Yagami R, Odagiri T
PLoS One. 2019; 14(11):e0224683.
PMID: 31697721
PMC: 6837752.
DOI: 10.1371/journal.pone.0224683.
Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes.
Hirotsu N, Sakaguchi H, Sato C, Ishibashi T, Baba K, Omoto S
Clin Infect Dis. 2019; 71(4):971-981.
PMID: 31538644
PMC: 7428393.
DOI: 10.1093/cid/ciz908.
Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.
Al Khatib H, Al Thani A, Gallouzi I, Yassine H
BMC Infect Dis. 2019; 19(1):314.
PMID: 30971204
PMC: 6458790.
DOI: 10.1186/s12879-019-3930-6.
Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016.
Bragstad K, Hungnes O, Litleskare I, Nyrerod H, Dorenberg D, Hauge S
Influenza Other Respir Viruses. 2019; 13(4):372-381.
PMID: 30834715
PMC: 6586177.
DOI: 10.1111/irv.12637.
Detection of neuraminidase inhibitor-resistant influenza A (H1N1)pdm09 viruses obtained from influenza surveillance in Indonesia.
Pawestri H, Nugraha A, Hariastuti N, Setiawaty V
SAGE Open Med. 2018; 6:2050312118818293.
PMID: 30574303
PMC: 6295675.
DOI: 10.1177/2050312118818293.
